Rojo-Tolosa, S.; González-Gutiérrez, M.V.; Sánchez-MartÃnez, J.A.; Jiménez-Gálvez, G.; Pineda-Lancheros, L.E.; Gálvez-Navas, J.M.; Jiménez-Morales, A.; Pérez-RamÃrez, C.; Morales-GarcÃa, C.
Impact of Omalizumab in Patients with Severe Uncontrolled Asthma and Possible Predictive Biomarkers of Response: A Real-Life Study. Pharmaceutics 2023, 15, 523.
https://doi.org/10.3390/pharmaceutics15020523
AMA Style
Rojo-Tolosa S, González-Gutiérrez MV, Sánchez-MartÃnez JA, Jiménez-Gálvez G, Pineda-Lancheros LE, Gálvez-Navas JM, Jiménez-Morales A, Pérez-RamÃrez C, Morales-GarcÃa C.
Impact of Omalizumab in Patients with Severe Uncontrolled Asthma and Possible Predictive Biomarkers of Response: A Real-Life Study. Pharmaceutics. 2023; 15(2):523.
https://doi.org/10.3390/pharmaceutics15020523
Chicago/Turabian Style
Rojo-Tolosa, Susana, MarÃa Victoria González-Gutiérrez, José Antonio Sánchez-MartÃnez, Gonzalo Jiménez-Gálvez, Laura Elena Pineda-Lancheros, José MarÃa Gálvez-Navas, Alberto Jiménez-Morales, Cristina Pérez-RamÃrez, and Concepción Morales-GarcÃa.
2023. "Impact of Omalizumab in Patients with Severe Uncontrolled Asthma and Possible Predictive Biomarkers of Response: A Real-Life Study" Pharmaceutics 15, no. 2: 523.
https://doi.org/10.3390/pharmaceutics15020523
APA Style
Rojo-Tolosa, S., González-Gutiérrez, M. V., Sánchez-MartÃnez, J. A., Jiménez-Gálvez, G., Pineda-Lancheros, L. E., Gálvez-Navas, J. M., Jiménez-Morales, A., Pérez-RamÃrez, C., & Morales-GarcÃa, C.
(2023). Impact of Omalizumab in Patients with Severe Uncontrolled Asthma and Possible Predictive Biomarkers of Response: A Real-Life Study. Pharmaceutics, 15(2), 523.
https://doi.org/10.3390/pharmaceutics15020523
